A supporter asks about the investigative report in Science magazine that suggests the critical study identifying beta-amyloid oligomers as the key actors in Alzheimer’s disease may have been based on fraudulent data.
Week Seven of our 2022 End of Year Campaign features AmyloSENS (Removing Junk from Between Cells) – with a disease focus on Challenging Heart Disease. Also featuring videos from Life Noggin, AMA with Dr. Sudhir Paul and Michael Rae.
Some scientists have reported that viruses, bacteria, and other pathogens may help drive Alzheimer’s and other neurodegenerative diseases, and that the body uses beta-amyloid protein to fight them off. That seems to imply that it’s a bad idea to remove Abeta from the brain. Here we explain how the SENS “damage-repair” strategy leaps over that therapeutic dilemma — just as it does with other kinds of aging damage.
Sign up to stay informed about the latest news and opportunities with SRF!
Use of this Web site constitutes acceptance of the Terms of Use and Privacy Policy.
© 2022 SENS Research Foundation – ALL RIGHTS RESERVED
